HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Grasso Selected Research

amatuximab

1/2018CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients.
1/2018Tumor-Shed Antigen Affects Antibody Tumor Targeting: Comparison of Two 89Zr-Labeled Antibodies Directed against Shed or Nonshed Antigens.
11/2015Tumor and organ uptake of (64)Cu-labeled MORAb-009 (amatuximab), an anti-mesothelin antibody, by PET imaging and biodistribution studies.
12/2007Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Grasso Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 08/2004
7Ovarian Neoplasms (Ovarian Cancer)
10/2017 - 03/2007
3Mesothelioma
01/2018 - 12/2007
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022
1Neoplasm Metastasis (Metastasis)
09/2015
1Hemangioma (Angioma)
04/2014
1Adenocarcinoma
12/2007
1Colorectal Neoplasms (Colorectal Cancer)
12/2007
1Autoimmune Diseases (Autoimmune Disease)
03/2006

Drug/Important Bio-Agent (IBA)

9Monoclonal AntibodiesIBA
11/2018 - 03/2007
8AntigensIBA
01/2022 - 03/2007
7farletuzumabIBA
08/2018 - 03/2007
6Proteins (Proteins, Gene)FDA Link
10/2017 - 08/2004
5Folate Receptor 1IBA
08/2018 - 03/2007
4MesothelinIBA
01/2018 - 12/2007
4amatuximabIBA
01/2018 - 12/2007
4ontuxizumabIBA
09/2015 - 03/2014
3taxaneIBA
08/2017 - 01/2017
3Carboplatin (JM8)FDA LinkGeneric
08/2017 - 01/2017
2Pemetrexed (MTA)FDA Link
12/2018 - 01/2018
2Complement System Proteins (Complement)IBA
11/2018 - 03/2007
2Pharmaceutical PreparationsIBA
08/2018 - 01/2014
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 11/2013
2AntibodiesIBA
01/2018 - 01/2017
1Rituximab (Mabthera)FDA Link
01/2022
1CA-125 Antigen (CA 125 Antigen)IBA
01/2022
1eribulinFDA Link
12/2018
1MORAb-202IBA
12/2018
1Lewis Y antigenIBA
01/2018
1Fluorescent Dyes (Fluorescent Probes)IBA
10/2017
1PlatinumIBA
08/2017
1Immunoglobulins (Immunoglobulin)IBA
01/2017
1AlbuminsIBA
01/2017
1Immunoconjugates (Immunoconjugate)IBA
01/2017
1Firefly LuciferasesIBA
04/2014
1Surface Antigens (Surface Antigen)IBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
12/2007
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2007
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2006
1Messenger RNA (mRNA)IBA
08/2004
1Alkylating AgentsIBA
08/2004

Therapy/Procedure

3Therapeutics
09/2017 - 01/2014
2Drug Therapy (Chemotherapy)
08/2017 - 12/2007
2Precision Medicine
04/2014 - 01/2014
1Immunotherapy
03/2007